Skip to main content
Walvax Biotechnology Co.,Ltd. logo

Walvax Biotechnology Co.,Ltd. — Investor Relations & Filings

Ticker · 300142 ISIN · CNE100000WN2 LEI · 300300H82R2DIQXA8N24 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,790 across all filing types
Latest filing 2019-10-09 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 300142

About Walvax Biotechnology Co.,Ltd.

https://www.walvax.com

Walvax Biotechnology Co.,Ltd. is a biopharmaceutical enterprise specializing in the research, development, production, and distribution of vaccines and other biological products. The company focuses on modern biotechnology to address public health challenges through a diverse portfolio of preventive vaccines. Key products include the 13-valent pneumococcal polysaccharide conjugate vaccine (PCV13), the bivalent human papillomavirus (HPV) vaccine, and various combination vaccines for meningitis and Haemophilus influenzae type b (Hib). Walvax operates advanced R&D platforms and manufacturing facilities that comply with international quality standards. The company is actively involved in the development of next-generation vaccine technologies, including mRNA and recombinant protein platforms, aiming to provide affordable and high-quality immunization solutions for global markets.

Recent filings

Filing Released Lang Actions
华创证券有限责任公司关于公司发行股份购买资产并募集配套资金部分限售股份解除限售的核查意见
Capital/Financing Update Classification · 95% confidence The document is a detailed independent financial advisor's verification opinion regarding the lifting of restrictions on certain restricted shares related to a share issuance for asset purchase and fundraising by Yunnan Watson Biotechnology Co., Ltd. It includes legal references, shareholding details, commitments by shareholders, and compliance with regulatory requirements. The document is not a full financial report but a specialized verification and opinion on share restriction lifting. It is not an announcement of a report publication but a substantive advisory opinion. This fits best under the category of Capital/Financing Update (CAP), as it relates to share issuance, asset purchase, and share restriction lifting, which are capital structure changes and financing activities.
2019-10-09 Chinese
关于公司发行股份购买资产并募集配套资金部分限售股份解除限售上市流通的提示性公告
Share Issue/Capital Change Classification · 95% confidence The document is a formal announcement from a company regarding the lifting of restrictions on certain shares previously subject to lock-up periods following a share issuance related to asset acquisition and fundraising. It details the number of shares becoming freely tradable, the dates, shareholder commitments, and compliance with regulatory requirements. The document does not contain financial statements or detailed financial analysis but rather focuses on the share unlocking event and related shareholder information. It is not an annual or interim report, earnings release, or management discussion. It is also not a proxy statement or voting result announcement. The content fits the category of a share issue or capital change announcement, specifically about the removal of share restrictions and the resulting change in share capital structure. Therefore, the appropriate classification is Share Issue/Capital Change (SHA). The document length is 3250 characters, which is consistent with an announcement rather than a full report.
2019-10-09 Chinese
关于2018年股票期权激励计划预留股票期权授予登记完成的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding the completion of the registration of reserved stock options granted under the company's 2018 stock option incentive plan. It includes information about the approval process, the number of options granted, the exercise price, the recipients, performance conditions, and the impact on financial results. The document is not a full financial report, earnings release, or management discussion but rather a formal announcement about stock option grants and related corporate governance matters. It does not fit categories like Annual Report, Earnings Release, or Management Reports. It is also not a simple notice of dividend or voting results. The content aligns with announcements related to capital structure changes, specifically stock option grants, which fall under Capital/Financing Update (CAP). The document length and detail confirm it is not a brief announcement or a regulatory filing fallback. Therefore, the best classification is Capital/Financing Update (CAP).
2019-09-10 Chinese
关于聘任公司高级管理人员、审计负责人暨部分高级管理人员离任的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the appointment and resignation of senior management personnel, including the appointment of a new audit leader and changes in vice presidents. It references compliance with stock exchange listing rules and company bylaws, and details shareholdings of departing executives. There is no financial data, earnings information, or report publication mentioned. The content clearly pertains to changes in the company's board or senior management rather than financial results or other report types.
2019-08-23 Chinese
关于BVI子公司签署JHBP（CY）HOLDINGS LIMITED股东协议等文件的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by a company regarding the signing of a shareholder agreement by its BVI subsidiary with another entity, JHBP (CY) Holdings Limited. It details the background, governance structure, rights, and obligations under the agreement, as well as opinions from the board, supervisors, and independent directors. The document does not contain financial statements or detailed financial performance data. It is an announcement of a corporate transaction related to shareholder agreements and governance, not a full report or financial filing. It is not a merger or acquisition filing, but rather an announcement of a related-party transaction and corporate governance matter. Given the nature of the content and the absence of financial data or report attachments, the most appropriate classification is Regulatory Filings (RNS), which serves as a fallback for miscellaneous regulatory announcements that do not fit other categories.
2019-08-23 Chinese
2019年半年度报告披露提示性公告
Report Publication Announcement Classification · 95% confidence The document is a short announcement (467 characters) indicating that the company has approved and published its 2019 half-year (semi-annual) report and summary on a regulatory website. It does not contain the actual financial statements or detailed report content but rather informs investors about the availability of the interim report. According to the 'Menu vs Meal' rule, such a brief notice about report disclosure is classified as a Report Publication Announcement (RPA), not the Interim Report (IR) itself.
2019-08-23 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.